ProfileGDS5678 / 1420958_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 12% 13% 12% 12% 7% 13% 11% 14% 13% 12% 12% 13% 12% 12% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.318612
GSM967853U87-EV human glioblastoma xenograft - Control 22.3120613
GSM967854U87-EV human glioblastoma xenograft - Control 32.3125312
GSM967855U87-EV human glioblastoma xenograft - Control 42.2489312
GSM967856U87-EV human glioblastoma xenograft - Control 52.118637
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.3710313
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.3021111
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.3302114
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.2929313
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.2974612
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.2955512
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.2945913
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.3018412
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.2983112